Option Greeks measure how Vertex Pharmaceuticals Inc (VRTX) option prices respond to changes in the stock price (delta and gamma), the passage of time (theta), implied volatility (vega), and interest rates (rho). These charts plot each Greek by strike, so you can see where an expiration's price risk, time decay, and volatility exposure are concentrated. VRTX implied volatility is near the middle of its one-year range, so delta and gamma cover about their usual range of strikes.
Upgrade to view higher order greeks (Vanna, Charm, and Vomma) and multiple expiration dates.
VRTX Option Greeks FAQ
What are option Greeks?
Option Greeks measure how an option's price responds to changes in the stock price (delta and gamma), time (theta), implied volatility (vega), and interest rates (rho).
How do I read the VRTX Greeks charts?
Gamma, theta, and vega are largest for strikes near the Vertex Pharmaceuticals stock price and shrink for strikes far above or below it. Theta grows as expiration gets closer, while vega is larger for expirations further out. Call delta runs from 0 to 1 and put delta from -1 to 0, near 0.50 and -0.50 at the money, and roughly estimates the chance that an option finishes in the money.
How does implied volatility affect VRTX's Greeks?
Vertex Pharmaceuticals IV rank is 51, so implied volatility is near the middle of its one-year range. Higher implied volatility raises option premiums and daily time decay (theta), and spreads delta and gamma across a wider range of strikes. Over the past year, 30-day implied volatility ranged from 22.8% to 48.3%. See the VRTX implied volatility history for a longer view.
How much gamma and delta do VRTX options carry in total?
Across all open Vertex Pharmaceuticals options on Nov 4, 2026, net gamma exposure was $4.18M and net delta exposure was $414.27M per 1% move in the stock. The VRTX gamma exposure chart shows where that gamma sits by strike.
What is Vertex Pharmaceuticals Inc?
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.